Chiron Real Estate (XRN) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
30 Jun, 2026Executive summary
Management focused on internal earnings growth, disciplined capital allocation, and external growth, with strong productivity in Q3 2025.
Rental revenue increased to $37.0M for Q3 2025, up 8.4% year-over-year, driven by acquisitions.
Net loss attributable to common stockholders was $6.0M for Q3 2025, mainly due to a $6.3M impairment loss on the Aurora, IL property and higher interest expense.
Completed a one-for-five reverse stock split and established a $50M share repurchase program; no shares repurchased as of November 3, 2025.
Five property acquisitions totaling $69.6M and five dispositions generating $13.4M in gross proceeds were completed in the first nine months of 2025.
Financial highlights
FFO for Q3 2025 was $14.5M ($1.00 per share/unit), and AFFO was $16.2M ($1.12 per share/unit), both up 4% per share year-over-year.
Total revenue for Q3 2025 was $37.2M, up $3.0M year-over-year; nine-month revenue was $109.8M.
Dividends per share were reduced to $0.75 in Q3 2025 from $1.05 in Q3 2024.
Weighted average interest rate on debt increased to 4.06% at September 30, 2025.
Portfolio leased occupancy was 95.2% as of September 30, 2025, with 5.2 million leasable square feet.
Outlook and guidance
Full-year 2025 AFFO per share and unit guidance narrowed to $4.50–$4.60.
Occupancy is expected to trend toward 96% by year-end, supported by a strong leasing pipeline.
Dividend reduction is intended to strengthen the balance sheet and support future growth.
Higher interest expense is expected in 2026 as new interest rate swaps take effect.
Guidance assumes no additional acquisitions/dispositions or equity/debt issuances beyond those already completed or announced.
Latest events from Chiron Real Estate
- Q3 2024 featured resilient occupancy, lower net income, and active acquisitions amid market challenges.XRN
Q3 20248 Jul 2026 - Portfolio shift to higher-return senior housing assets and JV unlocks $200M for reinvestment.XRN
Corporate presentation6 Jul 2026 - AFFO and FFO rose, occupancy remained high, and dividend was cut to support growth and stability.XRN
Q2 202530 Jun 2026 - AFFO guidance reaffirmed as net income rises and portfolio expands despite tenant bankruptcy.XRN
Q1 202530 Jun 2026 - Q2 net loss from property sale, but AFFO, occupancy, and acquisition activity remain strong.XRN
Q2 202430 Jun 2026 - Strong Q4 results and stable AFFO, with acquisitions and JV supporting 2025 growth.XRN
Q4 202430 Jun 2026 - Healthcare REIT registers Series C Preferred and Common Stock for resale by major investors.XRN
Registration filing16 Jun 2026 - $425M in senior housing acquisitions, $100M equity, and 36% dividend cut drive growth.XRN
Q1 202613 May 2026 - Strategic acquisitions and a diversified portfolio drive growth and support a well-covered dividend.XRN
Investor presentation7 May 2026